← Open Payments lookup

STEPHANIE STEVENSON: Open Payments

NPI 1659456184 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,798 in 78 payments from 10 companies in 2025. Trend: 2023 $838 · 2024 $867 · 2025 $1,798

Food & beverage: $1,698Education: $100
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$434
Neurocrine BioSciences, Inc.17$414
Janssen Pharmaceuticals, Inc11$272
Otsuka America Pharmaceutical, Inc.16$181
Teva Pharmaceuticals USA, Inc.6$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$116
Luye Pharma (USA) Ltd.2$89
Alkermes, Inc.3$88
Axsome Therapeutics, Inc.1$17
Lundbeck LLC1$17

Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, CAPLYTA, ERZOFRI EXTENDED-RELEASE, REXULTI, ARISTADA.

Industry payments across MI — which companies pay providers there.